Gene · 2285
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of an rAAV Producer Cell Line through Synthetic Biology. | ACS Synth Biol | 2022 | 36219557 | PubTator, text mining | PubMed |
| Emerging degrader technologies engaging lysosomal pathways. | Chem Soc Rev | 2022 | 36218065 | PubTator, text mining | PubMed |
| Cardiovascular effects of immunosuppression agents. | Front Cardiovasc Med | 2022 | 36211586 | PubTator, text mining | PubMed |
| Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia. | iScience | 2022 | 36193052 | PubTator, text mining | PubMed |
| Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1. | J Am Chem Soc | 2022 | 36170674 | PubTator, text mining | PubMed |
| Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors. | Viruses | 2022 | 36146786 | PubTator, text mining | PubMed |
| Targeted Protein Degradation to Overcome Resistance in Cancer Therapies: PROTAC and N-Degron Pathway. | Biomedicines | 2022 | 36140200 | PubTator, text mining | PubMed |
| Progesterone as an Anti-Inflammatory Drug and Immunomodulator: New Aspects in Hormonal Regulation of the Inflammation. | Biomolecules | 2022 | 36139138 | PubTator, text mining | PubMed |
| PROTACs: The Future of Leukemia Therapeutics. | Front Cell Dev Biol | 2022 | 36120561 | PubTator, text mining | PubMed |
| Proteomic mapping and optogenetic manipulation of membrane contact sites. | Biochem J | 2022 | 36111979 | PubTator, text mining | PubMed |
| Novel Design Strategies to Enhance the Efficiency of Proteolysis Targeting Chimeras. | ACS Pharmacol Transl Sci | 2022 | 36110375 | PubTator, text mining | PubMed |
| Recent advances of the mammalian target of rapamycin signaling in mesenchymal stem cells. | Front Genet | 2022 | 36110206 | PubTator, text mining | PubMed |
| Condensed-phase signaling can expand kinase specificity and respond to macromolecular crowding. | Mol Cell | 2022 | 36108633 | PubTator, text mining | PubMed |
| Tissue-restricted inhibition of mTOR using chemical genetics. | Proc Natl Acad Sci U S A | 2022 | 36095197 | PubTator, text mining | PubMed |
| DNA passes through cohesin's hinge as well as its Smc3-kleisin interface. | Elife | 2022 | 36094369 | PubTator, text mining | PubMed |
| Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis. | Int J Mol Sci | 2022 | 36077167 | PubTator, text mining | PubMed |
| Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development. | J Pathol | 2022 | 36073856 | PubTator, text mining | PubMed |
| A specific role for importin-5 and NASP in the import and nuclear hand-off of monomeric H3. | Elife | 2022 | 36066346 | PubTator, text mining | PubMed |
| Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs). | Chem Commun (Camb) | 2022 | 36065962 | PubTator, text mining | PubMed |
| Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia. | Cancer Discov | 2022 | 36053276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2285/papers?page=18